Diversity, Equity, Inclusion and Accessibility
I am part of a dedicated team of healthcare professionals, researchers, students and staff from different countries and various regions of the U.S. The culture of our Section is defined by the unique perspectives that we each bring with us. As both a large academic medical center and safety-net hospital serving the communities of Boston and its surroundings, our trainees engage in cutting edge research and gain real-world clinical experience by caring for local underserved populations. Our multilingual team is committed to promoting cultural competency, equity and inclusion in science, medicine and healthcare. We strive to maintain a workforce that is as diverse as the communities we serve, and aim to create a safe space for our members to learn, grow and succeed in their life goals. Acknowledging that we all have a role to play, I am dedicated to welcoming and celebrating individuals of all races, ethnicities, social backgrounds, religion, gender, sex, age, ability, sexual orientation, veteran status, and national origin.
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles
from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from the Boston VA. We are only showing grant title, and only for people in the role of PI.
GBT-GBT440-043-US-01-045 Voxelotor Cerebral Hemodynamics Study10/21/2022 - 10/21/2027 (PI)
Global Blood Therapeutics, Inc.
ALXN1820-SCD-20107/11/2023 - 07/10/2026 (PI)
Alexion Pharmaceuticals
GBT440-4R2: An Open Label, Observational, Prospective Registry of Participants With Sickle Cell Disease (SCD) Treated With Oxbryta (Voxelotor).12/02/2022 - 12/01/2025 (PI)
Global Blood Therapeutics, Inc.
AG946-C-001: A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Subjects with Sickle Cell Disease07/25/2022 - 07/24/2025 (PI)
Agios Pharmaceuticals, Inc.
AG348-C-020: A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease07/18/2022 - 07/17/2025 (PI)
Agios Pharmaceuticals, Inc.
Anonymized cellular determinants of red cells sickling03/27/2023 - 03/26/2024 (PI)
Tessera Therapeutics, Inc
|
Yr
|
Title
|
Project-Sub Proj
|
Pubs
|
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Pollock G, Negre O, Ribeil JA. Gene-addition/editing therapy in sickle cell disease. Presse Med. 2023 Dec; 52(4):104214.View Related Profiles. PMID: 38000628
-
-
Ribeil JA, Pollock G, Frangoul H, Steinberg MH. An integrated therapeutic approach to sickle cell disease management beyond infancy. Am J Hematol. 2023 Jul; 98(7):1087-1096.View Related Profiles. PMID: 37170801
-
Kanter J, Thompson AA, Pierciey FJ, Hsieh M, Uchida N, Leboulch P, Schmidt M, Bonner M, Guo R, Miller A, Ribeil JA, Davidson D, Asmal M, Walters MC, Tisdale JF. Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study. Am J Hematol. 2023 Jan; 98(1):11-22. PMID: 36161320; PMCID: PMC10092845; DOI: 10.1002/ajh.26741;
-
Magrin E, Semeraro M, Hebert N, Joseph L, Magnani A, Chalumeau A, Gabrion A, Roudaut C, Marouene J, Lefrere F, Diana JS, Denis A, Neven B, Funck-Brentano I, Negre O, Renolleau S, Brousse V, Kiger L, Touzot F, Poirot C, Bourget P, El Nemer W, Blanche S, Tréluyer JM, Asmal M, Walls C, Beuzard Y, Schmidt M, Hacein-Bey-Abina S, Asnafi V, Guichard I, Poirée M, Monpoux F, Touraine P, Brouzes C, de Montalembert M, Payen E, Six E, Ribeil JA, Miccio A, Bartolucci P, Leboulch P, Cavazzana M. Long-term outcomes of lentiviral gene therapy for the ß-hemoglobinopathies: the HGB-205 trial. Nat Med. 2022 01; 28(1):81-88. PMID: 35075288
-
Kanter J, Walters MC, Krishnamurti L, Mapara MY, Kwiatkowski JL, Rifkin-Zenenberg S, Aygun B, Kasow KA, Pierciey FJ, Bonner M, Miller A, Zhang X, Lynch J, Kim D, Ribeil JA, Asmal M, Goyal S, Thompson AA, Tisdale JF. Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. N Engl J Med. 2022 02 17; 386(7):617-628. PMID: 34898139
-
Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F, Lucchini MJ, Machin J, Nimubona S, Ribeil JA, Galacteros F, Cannas G, Hot A. Pregnancy outcome in women with transfused beta-thalassemia in France. Ann Hematol. 2022 Feb; 101(2):289-296. PMID: 34668980
-
Ribeil JA. Primary myelofibrosis in untreated sickle cell disease: Are adult patients at higher risk for developing hematological myeloid neoplasms? Am J Hematol. 2022 01 01; 97(1):4-6. PMID: 34626435; DOI: 10.1002/ajh.26371;
-
Chauvet M, Chhuon C, Lipecka J, Dechavanne S, Dechavanne C, Lohezic M, Ortalli M, Pineau D, Ribeil JA, Manceau S, Le Van Kim C, Luty AJF, Migot-Nabias F, Azouzi S, Guerrera IC, Merckx A. Sickle Cell Trait Modulates the Proteome and Phosphoproteome of Plasmodium falciparum-Infected Erythrocytes. Front Cell Infect Microbiol. 2021; 11:637604. PMID: 33842387; PMCID: PMC8024585; DOI: 10.3389/fcimb.2021.637604;
-
Joseph L, Jean C, Manceau S, Chalas C, Arnaud C, Kamdem A, Pondarré C, Habibi A, Bernaudin F, Allali S, de Montalembert M, Boutonnat-Faucher B, Arlet JB, Koehl B, Cavazzana M, Ribeil JA, Lionnet F, Berthaut I, Brousse V. Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease. Blood. 2021 02 11; 137(6):826-829. PMID: 32976551; DOI: 10.1182/blood.2020006270;
Showing 10 of 70 results.
Show More
-
Tisdale JF, Pierciey FJ, Bonner M, Thompson AA, Krishnamurti L, Mapara MY, Kwiatkowski JL, Shestopalov I, Ribeil JA, Huang W, Asmal M, Kanter J, Walters MC. Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial. Am J Hematol. 2020 09; 95(9):E239-E242. PMID: 32401372; DOI: 10.1002/ajh.25867;
-
Denoix E, Bomahou C, Clavier L, Ribeil JA, Lionnet F, Bartolucci P, Courbebaisse M, Pouchot J, Arlet JB. Primary Hyperparathyroidism in Sickle Cell Disease: An Unknown Complication of the Disease in Adulthood. J Clin Med. 2020 Jan 22; 9(2). PMID: 31979085; PMCID: PMC7073651; DOI: 10.3390/jcm9020308;
-
McArthur JG, Svenstrup N, Chen C, Fricot A, Carvalho C, Nguyen J, Nguyen P, Parachikova A, Abdulla F, Vercellotti GM, Hermine O, Edwards D, Ribeil JA, Belcher JD, Maciel TT. A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease. Haematologica. 2020 03; 105(3):623-631. PMID: 31147439; PMCID: PMC7049346; DOI: 10.3324/haematol.2018.213462;
-
Coquerelle S, Ghardallou M, Rais S, Taupin P, Touzot F, Boquet L, Blanche S, Benaouadi S, Brice T, Tuchmann-Durand C, Ribeil JA, Magrin E, Lissillour E, Rochaix L, Cavazzana M, Durand-Zaleski I. Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation. Hum Gene Ther. 2019 06; 30(6):753-761. PMID: 30700149; DOI: 10.1089/hum.2018.178;
-
Cappellini MD, Porter J, Origa R, Forni GL, Voskaridou E, Galactéros F, Taher AT, Arlet JB, Ribeil JA, Garbowski M, Graziadei G, Brouzes C, Semeraro M, Laadem A, Miteva D, Zou J, Sung V, Zinger T, Attie KM, Hermine O. Sotatercept, a novel transforming growth factor ß ligand trap, improves anemia in ß-thalassemia: a phase II, open-label, dose-finding study. Haematologica. 2019 03; 104(3):477-484. PMID: 30337358; PMCID: PMC6395345; DOI: 10.3324/haematol.2018.198887;
-
Nguyen-Khoa T, Mine L, Allaf B, Ribeil JA, Remus C, Stanislas A, Gauthereau V, Enouz S, Kim JS, Yang X, Gluckman E, Beaudeux JL, Munnich A, Girot R, Cavazzana M. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease. Ann Biol Clin (Paris). 2018 Aug 01; 76(4):416-420. PMID: 29976532; DOI: 10.1684/abc.2018.1354;
-
Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chrétien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M. Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia. N Engl J Med. 2018 04 19; 378(16):1479-1493. PMID: 29669226; DOI: 10.1056/NEJMoa1705342;
-
Ribeil JA, Labopin M, Stanislas A, Deloison B, Lemercier D, Habibi A, Albinni S, Charlier C, Lortholary O, Lefrere F, De Montalembert M, Blanche S, Galactéros F, Tréluyer JM, Gluckman E, Ville Y, Joseph L, Delville M, Benachi A, Cavazzana M. Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory. Am J Hematol. 2018 06; 93(6):794-802. PMID: 29603363; PMCID: PMC6001537; DOI: 10.1002/ajh.25097;
-
Lagresle-Peyrou C, Lefrère F, Magrin E, Ribeil JA, Romano O, Weber L, Magnani A, Sadek H, Plantier C, Gabrion A, Ternaux B, Félix T, Couzin C, Stanislas A, Tréluyer JM, Lamhaut L, Joseph L, Delville M, Miccio A, André-Schmutz I, Cavazzana M. Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion. Haematologica. 2018 05; 103(5):778-786. PMID: 29472357; PMCID: PMC5927997; DOI: 10.3324/haematol.2017.184788;
-
De Luna G, Ranque B, Courbebaisse M, Ribeil JA, Khimoud D, Dupeux S, Silvera J, Offredo L, Pouchot J, Arlet JB. High bone mineral density in sickle cell disease: Prevalence and characteristics. Bone. 2018 05; 110:199-203. PMID: 29428552; DOI: 10.1016/j.bone.2018.02.003;
-
Bonnet S, Guédon A, Ribeil JA, Suarez F, Tamburini J, Gaujoux S. Indications and outcome of splenectomy in hematologic disease. J Visc Surg. 2017 Dec; 154(6):421-429. PMID: 28757383; DOI: 10.1016/j.jviscsurg.2017.06.011;
-
Kormann R, Jannot AS, Narjoz C, Ribeil JA, Manceau S, Delville M, Joste V, Prié D, Pouchot J, Thervet E, Courbebaisse M, Arlet JB. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target. Br J Haematol. 2017 10; 179(2):323-335. PMID: 28699644; DOI: 10.1111/bjh.14842;
-
-
de Montalembert M, Ribeil JA, Brousse V, Guerci-Bresler A, Stamatoullas A, Vannier JP, Dumesnil C, Lahary A, Touati M, Bouabdallah K, Cavazzana M, Chauzit E, Baptiste A, Lefebvre T, Puy H, Elie C, Karim Z, Ernst O, Rose C. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome. PLoS One. 2017; 12(3):e0172147. PMID: 28257476; PMCID: PMC5336214; DOI: 10.1371/journal.pone.0172147;
-
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, Caccavelli L, Neven B, Bourget P, El Nemer W, Bartolucci P, Weber L, Puy H, Meritet JF, Grevent D, Beuzard Y, Chrétien S, Lefebvre T, Ross RW, Negre O, Veres G, Sandler L, Soni S, de Montalembert M, Blanche S, Leboulch P, Cavazzana M. Gene Therapy in a Patient with Sickle Cell Disease. N Engl J Med. 2017 03 02; 376(9):848-855. PMID: 28249145; DOI: 10.1056/NEJMoa1609677;
-
Delville M, Manceau S, Ait Abdallah N, Stolba J, Awad S, Damy T, Gellen B, Sabbah L, Debbache K, Audard V, Beaumont JL, Arnaud C, Chantalat-Auger C, Driss F, Lefrère F, Cavazzana M, Franco G, Galacteros F, Ribeil JA, Gellen-Dautremer J. Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes. Am J Hematol. 2017 Feb; 92(2):136-140. PMID: 27813144; DOI: 10.1002/ajh.24600;
-
Courbebaisse M, Mehel H, Petit-Hoang C, Ribeil JA, Sabbah L, Tuloup-Minguez V, Bergerat D, Arlet JB, Stanislas A, Souberbielle JC, Le Clésiau H, Fischmeister R, Friedlander G, Prié D. Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease. Haematologica. 2017 02; 102(2):e33-e35. PMID: 27789679; PMCID: PMC5286949; DOI: 10.3324/haematol.2016.150987;
-
Ohayon D, De Chiara A, Chapuis N, Candalh C, Mocek J, Ribeil JA, Haddaoui L, Ifrah N, Hermine O, Bouillaud F, Frachet P, Bouscary D, Witko-Sarsat V. Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia. Sci Rep. 2016 10 19; 6:35561. PMID: 27759041; PMCID: PMC5069676; DOI: 10.1038/srep35561;
-
Cavazzana M, Ribeil JA, Lagresle-Peyrou C, André-Schmutz I. Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View. Stem Cells Dev. 2017 01 15; 26(2):71-76. PMID: 27750026; PMCID: PMC5248546; DOI: 10.1089/scd.2016.0230;
-
Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, Hongeng S, Hacein-Bey S, Cavazzana M, Leboulch P, Payen E. Gene Therapy of the ß-Hemoglobinopathies by Lentiviral Transfer of the ß(A(T87Q))-Globin Gene. Hum Gene Ther. 2016 Feb; 27(2):148-65. PMID: 26886832; PMCID: PMC4779296; DOI: 10.1089/hum.2016.007;
-
Millet A, Martin KR, Bonnefoy F, Saas P, Mocek J, Alkan M, Terrier B, Kerstein A, Tamassia N, Satyanarayanan SK, Ariel A, Ribeil JA, Guillevin L, Cassatella MA, Mueller A, Thieblemont N, Lamprecht P, Mouthon L, Perruche S, Witko-Sarsat V. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest. 2015 Nov 02; 125(11):4107-21. PMID: 26436651; PMCID: PMC4639994; DOI: 10.1172/JCI78182;
-
Habibi A, Arlet JB, Stankovic K, Gellen-Dautremer J, Ribeil JA, Bartolucci P, Lionnet F. [French guidelines for the management of adult sickle cell disease: 2015 update]. Rev Med Interne. 2015 May 11; 36(5 Suppl 1):5S3-84. PMID: 26007619; DOI: 10.1016/S0248-8663(15)60002-9;
-
Arlet JB, Ribeil JA, Guillem F, Hermine O, Courtois G. [HSP70 regulates ineffective erythropoiesis in beta-thalassaemia]. Med Sci (Paris). 2015 Jan; 31(1):9-11. PMID: 25658720; DOI: 10.1051/medsci/20153101002;
-
Picot J, Ndour PA, Lefevre SD, El Nemer W, Tawfik H, Galimand J, Da Costa L, Ribeil JA, de Montalembert M, Brousse V, Le Pioufle B, Buffet P, Le Van Kim C, Français O. A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen. Am J Hematol. 2015 Apr; 90(4):339-45. PMID: 25641515; DOI: 10.1002/ajh.23941;
-
Arlet JB, Ribeil JA, Guillem F, Negre O, Hazoume A, Marcion G, Beuzard Y, Dussiot M, Moura IC, Demarest S, de Beauchêne IC, Belaid-Choucair Z, Sevin M, Maciel TT, Auclair C, Leboulch P, Chretien S, Tchertanov L, Baudin-Creuza V, Seigneuric R, Fontenay M, Garrido C, Hermine O, Courtois G. HSP70 sequestration by free a-globin promotes ineffective erythropoiesis in ß-thalassaemia. Nature. 2014 Oct 09; 514(7521):242-6. PMID: 25156257; DOI: 10.1038/nature13614;
-
Dussiot M, Maciel TT, Fricot A, Chartier C, Negre O, Veiga J, Grapton D, Paubelle E, Payen E, Beuzard Y, Leboulch P, Ribeil JA, Arlet JB, Coté F, Courtois G, Ginzburg YZ, Daniel TO, Chopra R, Sung V, Hermine O, Moura IC. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in ß-thalassemia. Nat Med. 2014 Apr; 20(4):398-407. PMID: 24658077; PMCID: PMC7730561; DOI: 10.1038/nm.3468;
-
Hermine O, Arlet JB, Ribeil JA, Guillerm F, Vandekerkhove J, Courtois G. [HSP70, an erythropoiesis regulator that determines the fate of erythroblasts between death and differentiation]. Transfus Clin Biol. 2013 May; 20(2):144-7. PMID: 23643330; DOI: 10.1016/j.tracli.2013.03.005;
-
Ribeil JA, Arlet JB, Dussiot M, Moura IC, Courtois G, Hermine O. Ineffective erythropoiesis in ß -thalassemia. ScientificWorldJournal. 2013; 2013:394295. PMID: 23606813; PMCID: PMC3628659; DOI: 10.1155/2013/394295;
-
Arlet JB, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, de Montalembert M, Prié D, Pouchot J, Ribeil JA. Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults. Bone. 2013 Jan; 52(1):206-11. PMID: 23072921; DOI: 10.1016/j.bone.2012.10.005;
-
Arlet JB, Ribeil JA, Chatellier G, Eladari D, De Seigneux S, Souberbielle JC, Friedlander G, de Montalembert M, Pouchot J, Prié D, Courbebaisse M. Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study. BMC Nephrol. 2012 Aug 06; 13:83. PMID: 22866669; PMCID: PMC3465224; DOI: 10.1186/1471-2369-13-83;
-
Lefrère F, Mauge L, Réa D, Ribeil JA, Dal Cortivo L, Brignier AC, Aoun C, Larghéro J, Cavazzana-Calvo M, Micléa JM. A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure. Transfusion. 2013 Mar; 53(3):564-9. PMID: 22725259; DOI: 10.1111/j.1537-2995.2012.03744.x;
-
Dhédin N, Prébet T, De Latour RP, Katsahian S, Kuentz M, Piard N, Réa D, Norol F, Jouet JP, Ribeil JA, Tabrizi R, Rio B, Lioure B, Tiberghien P, Bourhis JH, Sirvent A, Bordigoni P, Blaise D, Michallet M, Vernant JP. Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation. Bone Marrow Transplant. 2012 Dec; 47(12):1564-8. PMID: 22609881
-
Bader-Meunier B, Monnet D, Barnerias C, Halphen I, Lambot-Juhan K, Chalumeau M, Costedoat-Chalumeau N, Ribeil JA, Bodemer C, Gherardi R. Thrombotic microangiopathy and Purtscher-like retinopathy as a rare presentation of juvenile dermatomyositis. Pediatrics. 2012 Mar; 129(3):e821-4. PMID: 22311994
-
Frisan E, Vandekerckhove J, de Thonel A, Pierre-Eugène C, Sternberg A, Arlet JB, Floquet C, Gyan E, Kosmider O, Dreyfus F, Gabet AS, Courtois G, Vyas P, Ribeil JA, Zermati Y, Lacombe C, Mayeux P, Solary E, Garrido C, Hermine O, Fontenay M. Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes. Blood. 2012 Feb 09; 119(6):1532-42. PMID: 22160620
-
Quesnel S, Nguyen Y, Campo P, Hermine O, Ribeil JA, Elmaleh M, Grayeli AB, Ferrary E, Sterkers O, Couloigner V. Protective effect of systemic administration of erythropoietin on auditory brain stem response and compound action potential thresholds in an animal model of cochlear implantation. Ann Otol Rhinol Laryngol. 2011 Nov; 120(11):737-47. PMID: 22224316
-
Coulon S, Dussiot M, Grapton D, Maciel TT, Wang PH, Callens C, Tiwari MK, Agarwal S, Fricot A, Vandekerckhove J, Tamouza H, Zermati Y, Ribeil JA, Djedaini K, Oruc Z, Pascal V, Courtois G, Arnulf B, Alyanakian MA, Mayeux P, Leanderson T, Benhamou M, Cogné M, Monteiro RC, Hermine O, Moura IC. Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat Med. 2011 Oct 23; 17(11):1456-65. PMID: 22019886
-
Arlet JB, Ribeil JA, Chatellier G, Pouchot J, de Montalembert M, Prié D, Courbebaisse M. [Hyperuricemia in sickle cell disease in France]. Rev Med Interne. 2012 Jan; 33(1):13-7. PMID: 21907467
-
Mesnard L, Rafat C, Vandermeersch S, Hertig A, Cathelin D, Xu-Dubois YC, Jouanneau C, Keller AC, Ribeil JA, Leite-de-Moraes MC, Rondeau E. Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis. FASEB J. 2011 Oct; 25(10):3543-53. PMID: 21764994
-
Schneider E, Machavoine F, Bricard-Rignault R, Levasseur M, Petit-Bertron AF, Gautron S, Ribeil JA, Launay JM, Mecheri S, Côté F, Dy M. Downregulation of basophil-derived IL-4 and in vivo T(H)2 IgE responses by serotonin and other organic cation transporter 3 ligands. J Allergy Clin Immunol. 2011 Oct; 128(4):864-871.e2. PMID: 21636115
-
Arlet JB, Pouchot J, Ribeil JA. [Abnormal tongue]. Rev Med Interne. 2012 Apr; 33(4):227-8. PMID: 21492972
-
Lefrère F, Brignier AC, Elie C, Ribeil JA, Bernimoulin M, Aoun C, Dal Cortivo L, Delarue R, Hermine O, Cavazzana-Calvo M. First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony-stimulating factor. Adv Ther. 2011 Apr; 28(4):304-10. PMID: 21400232
-
Gabet AS, Coulon S, Fricot A, Vandekerckhove J, Chang Y, Ribeil JA, Lordier L, Zermati Y, Asnafi V, Belaid Z, Debili N, Vainchenker W, Varet B, Hermine O, Courtois G. Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling. Cell Death Differ. 2011 Apr; 18(4):678-89. PMID: 21072057
-
Witko-Sarsat V, Mocek J, Bouayad D, Tamassia N, Ribeil JA, Candalh C, Davezac N, Reuter N, Mouthon L, Hermine O, Pederzoli-Ribeil M, Cassatella MA. Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival. J Exp Med. 2010 Nov 22; 207(12):2631-45. PMID: 20975039
-
de Thonel A, Vandekerckhove J, Lanneau D, Selvakumar S, Courtois G, Hazoume A, Brunet M, Maurel S, Hammann A, Ribeil JA, Zermati Y, Gabet AS, Boyes J, Solary E, Hermine O, Garrido C. HSP27 controls GATA-1 protein level during erythroid cell differentiation. Blood. 2010 Jul 08; 116(1):85-96. PMID: 20410505
-
Callens C, Coulon S, Naudin J, Radford-Weiss I, Boissel N, Raffoux E, Wang PH, Agarwal S, Tamouza H, Paubelle E, Asnafi V, Ribeil JA, Dessen P, Canioni D, Chandesris O, Rubio MT, Beaumont C, Benhamou M, Dombret H, Macintyre E, Monteiro RC, Moura IC, Hermine O. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med. 2010 Apr 12; 207(4):731-50. PMID: 20368581
-
Arlet JB, Bartolucci P, Habibi A, Ribeil JA, Stankovic K, Lionnet F. [Anemia in adult sickle cell disease]. Rev Med Interne. 2009 Dec; 30 Suppl 4:S319-22. PMID: 19836111
-
Lionnet F, Arlet JB, Bartolucci P, Habibi A, Ribeil JA, Stankovic K. [Guidelines for management of adult sickle cell disease]. Rev Med Interne. 2009 Sep; 30 Suppl 3:S162-223. PMID: 19713011
-
Jedidi A, Marty C, Oligo C, Jeanson-Leh L, Ribeil JA, Casadevall N, Galy A, Vainchenker W, Villeval JL. Selective reduction of JAK2V617F-dependent cell growth by siRNA/shRNA and its reversal by cytokines. Blood. 2009 Aug 27; 114(9):1842-51. PMID: 19589925
-
Rafat C, Fakhouri F, Ribeil JA, Delarue R, Le Quintrec M. Fanconi syndrome due to deferasirox. Am J Kidney Dis. 2009 Nov; 54(5):931-4. PMID: 19493602
-
Martinuzzi E, Scotto M, Enée E, Brezar V, Ribeil JA, van Endert P, Mallone R. Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection. J Immunol Methods. 2008 Apr 20; 333(1-2):61-70. PMID: 18242633
-
Vandekerckhove J, Ribeil JA, Zermati Y, Garrido C, Courtois G, Solary E, Hermine O. [Hsp 70, guardian angel of GATA-1 during erythroid differentiation]. Med Sci (Paris). 2008 Jan; 24(1):37-40. PMID: 18198108
-
Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. Transfusion. 2007 Oct; 47(10):1830-6. PMID: 17880608
-
Lefrère F, Zohar S, Beaudier S, Audat F, Ribeil JA, Ghez D, Varet B, Cavazzana-Calvo M, Dal Cortivo L, Letestu R, McIntyre E, Brouzes C. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis. Transfusion. 2007 Oct; 47(10):1851-7. PMID: 17880611
-
Ribeil JA, Zermati Y, Vandekerckhove J, Cathelin S, Kersual J, Dussiot M, Coulon S, Moura IC, Zeuner A, Kirkegaard-Sørensen T, Varet B, Solary E, Garrido C, Hermine O. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature. 2007 Jan 04; 445(7123):102-5. PMID: 17167422
-
Pocaly M, Lagarde V, Etienne G, Ribeil JA, Claverol S, Bonneu M, Moreau-Gaudry F, Guyonnet-Duperat V, Hermine O, Melo JV, Dupouy M, Turcq B, Mahon FX, Pasquet JM. Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia. Leukemia. 2007 Jan; 21(1):93-101. PMID: 17109025
-
Booth C, Ribeil JA, Audat F, Dal-Cortivo L, Veys PA, Thrasher AJ, Davies EG, Lefrère F, Fischer A, Cavazzana-Calvo M, Gaspar HB. CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies. Br J Haematol. 2006 Nov; 135(4):533-7. PMID: 17054675
-
Lefrère F, Zohar S, Ghez D, Delarue R, Audat F, Suarez F, Hermine O, Damaj G, Maillard N, Ribeil JA, Azagury M, Misbahi R, Jondeau K, Cavazzana-Calvo M, Dal Cortivo L, Varet B. The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients. Bone Marrow Transplant. 2006 Apr; 37(8):725-9. PMID: 16518433
-
Ribeil JA, Zermati Y, Vandekerckhove J, Dussiot M, Kersual J, Hermine O. [Erythropoiesis: a paradigm for the role of caspases in cell death and differentiation]. J Soc Biol. 2005; 199(3):219-31. PMID: 16471262
-
Gisserot O, de Jaureguiberry JP, Ribeil JA, Villemagne B, Jaubert D. [Cerebral glioblastoma complicating the course of myeloma]. Presse Med. 1997 Sep 06; 26(25):1197. PMID: 9380614
-
Galzin M, de Jaureguiberry JP, Ribeil JA, Pujol A, Lescout JM, Calvet A, Billant JB, Jaubert D. [Meningeal tumor]. Rev Med Interne. 1997; 18(11):906-7. PMID: 9499992
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 1997 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 8 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 3 |
2013 Paris, France:
Necker Hospital Pain Management Committee Annual Prize
2012 French Society of Hematology, France:
Presentation Award
2010 Paris VII University, France:
Ph.D. Distinction and summa cum laude
2007 French Society of Hematology, France:
Horiba Abx Cellular Hematology Award
2007 Congress of Young Researchers in Biology (3rd prize,) France:
René Descartes Award
2000 University of Limoges, France:
Clinical Fellow Gold Medal